SCHEMBL15545277

SCHEMBL15545277

O=C(C1CNc2cc(C(F)(F)F)ccc21)C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
CNR2 P34972 1/20 0.44
RXFP1 Q9HBX9 1/20 0.42
EPHX2 P34913 1/20 0.40
KCNQ3 O43525 2/20 0.40
KCNQ2 O43526 2/20 0.40
CHRNB2 P17787 2/20 0.39
CHRNA4 P43681 2/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
P2RX4 Q99571 1/20 0.35
P2RX7 Q99572 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15544668 0.82 ALDH1A1 (0.43) SMN1; SMN2EPHX2CYP17A1CYP19A1P2RX4
SCHEMBL4980558 0.79 CHRNB2 (0.43) SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL15545602 0.78 ALDH1A1 (0.35) SMN1; SMN2CNR2KCNQ3KCNQ2CHRNB2
SCHEMBL15545467 0.78 KCNH2 (0.41) CNR2CYP17A1CYP19A1P2RX7KDM4E
SCHEMBL15545879 0.77 ALDH1A1 (0.44) SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL15544370 0.76 CNR2 (0.41) SMN1; SMN2CNR2KCNQ3KCNQ2CHRNB2
SCHEMBL15544852 0.74 LMNA (0.43) SMN1; SMN2EPHX2CHRNB2CHRNA4CYP17A1
SCHEMBL15545052 0.73 P2RX4 (0.39) CNR2CYP17A1CYP19A1P2RX4P2RX7
SCHEMBL15544368 0.70 ALDH1A1 (0.44) SMN1; SMN2CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL15545182 0.69 KCNH2 (0.42) CNR2EPHX2CYP17A1CYP19A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870139-A1 NOVEL ADAMANTYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS F. Hoffmann-La Roche AG (CH) 2015-05-13 EP disclosed
WO-2014005968-A1 NOVEL ADAMANTYL DERIVATIVES AS CANNABINOID RECEPTOR 2 AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2014-01-09 WO disclosed